广州维力医疗器械股份有限公司 关于控股股东部分股份质押的公告

Group 1 - The core point of the announcement is that the controlling shareholder, Gaobo Investment (Hong Kong) Co., Ltd., holds 92.0192 million shares of the company, accounting for 31.53% of the total share capital, and has pledged 46 million shares, which is 49.99% of its holdings and 15.76% of the total share capital [1] - The pledged shares are not used as collateral for major asset restructuring performance compensation or other guarantee purposes [1] - Gaobo Investment and its concerted parties have a cumulative pledge of shares, which is detailed in the announcement [1] Group 2 - The announcement states that the stock pledge will not lead to a change in the actual control of the company by Gaobo Investment [1] - Gaobo Investment has a good repayment ability and sufficient risk control capacity, with no current risk of forced liquidation [1] - The company will continue to monitor the share pledge risk of Gaobo Investment and fulfill its information disclosure obligations based on actual circumstances [1]